Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Axelsson

Showing results (11-20 of 82) with videos related to

Pageof 9
Sort By:
BMC Medicine|October 14, 2025
Association between pro-inflammatory proteins and neurofilament in plasma from persons with epilepsyMayuresh Sarangdhar, Sarah Akel, Saman Hosseini Ashtiani, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 16, 2021
Exploring CSF neurofilament light as a biomarker for MS in clinical practice; a retrospective registry-based studyIgal Rosenstein, Markus Axelsson, Lenka Novakova, et al.
BMJ Neurology Open|December 22, 2025
Blood biomarkers of seizures in epilepsy: machine learning reveals altered plasma proteomeSarah Akel, Saman Hosseini Ashtiani, Mayuresh Anant Sarangdhar, et al.
Journal of Neuroimmunology|March 6, 2016
YKL-40 is a CSF biomarker of intrathecal inflammation in secondary progressive multiple sclerosisJoachim Burman, Raili Raininko, Kaj Blennow, et al.
Journal of Neuroimmunology|March 4, 2014
CSF levels of YKL-40 are increased in MS and replaces with immunosuppressive treatmentClas Malmeström, Markus Axelsson, Jan Lycke, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 18, 2025
Quality of life is decreased in persons with relapsing-remitting multiple sclerosis experiencing progression independent of relapse activitySarah Lindberg, Sofia Sandgren, Markus Axelsson, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 17, 2025
Lymphocyte Dynamics and the Emergence of Secondary Autoimmunity Following Immune Reconstitution Therapies in Multiple SclerosisSofia Sandgren, Lenka Novakova, Markus Axelsson, et al.
Epilepsia|July 20, 2023
Neurofilament light, glial fibrillary acidic protein, and tau in a regional epilepsy cohort: High plasma levels are rare but related to seizuresSarah Akel, Fredrik Asztely, Rakesh Kumar Banote, et al.
Journal of Neurochemistry|September 3, 2021
Kappa free light chain index as a diagnostic biomarker in multiple sclerosis: A real-world investigationIgal Rosenstein, Sofia Rasch, Markus Axelsson, et al.
BMC Immunology|July 31, 2013
MicroRNA regulate immune pathways in T-cells in multiple sclerosis (MS)Margareta Jernås, Clas Malmeström, Markus Axelsson, et al.
Pageof 9

Showing results (11-20 of 82) with videos related to

Sort By:
Pageof 9
BMC Medicine|October 14, 2025
Association between pro-inflammatory proteins and neurofilament in plasma from persons with epilepsyMayuresh Sarangdhar, Sarah Akel, Saman Hosseini Ashtiani, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 16, 2021
Exploring CSF neurofilament light as a biomarker for MS in clinical practice; a retrospective registry-based studyIgal Rosenstein, Markus Axelsson, Lenka Novakova, et al.
BMJ Neurology Open|December 22, 2025
Blood biomarkers of seizures in epilepsy: machine learning reveals altered plasma proteomeSarah Akel, Saman Hosseini Ashtiani, Mayuresh Anant Sarangdhar, et al.
Journal of Neuroimmunology|March 6, 2016
YKL-40 is a CSF biomarker of intrathecal inflammation in secondary progressive multiple sclerosisJoachim Burman, Raili Raininko, Kaj Blennow, et al.
Journal of Neuroimmunology|March 4, 2014
CSF levels of YKL-40 are increased in MS and replaces with immunosuppressive treatmentClas Malmeström, Markus Axelsson, Jan Lycke, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 18, 2025
Quality of life is decreased in persons with relapsing-remitting multiple sclerosis experiencing progression independent of relapse activitySarah Lindberg, Sofia Sandgren, Markus Axelsson, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 17, 2025
Lymphocyte Dynamics and the Emergence of Secondary Autoimmunity Following Immune Reconstitution Therapies in Multiple SclerosisSofia Sandgren, Lenka Novakova, Markus Axelsson, et al.
Epilepsia|July 20, 2023
Neurofilament light, glial fibrillary acidic protein, and tau in a regional epilepsy cohort: High plasma levels are rare but related to seizuresSarah Akel, Fredrik Asztely, Rakesh Kumar Banote, et al.
Journal of Neurochemistry|September 3, 2021
Kappa free light chain index as a diagnostic biomarker in multiple sclerosis: A real-world investigationIgal Rosenstein, Sofia Rasch, Markus Axelsson, et al.
BMC Immunology|July 31, 2013
MicroRNA regulate immune pathways in T-cells in multiple sclerosis (MS)Margareta Jernås, Clas Malmeström, Markus Axelsson, et al.
Pageof 9